Cancer vaccine (Product is a specific actie immunotherapeutic composed of antigen-loaded autologous antigen presenting cells designed to stimulate a T cell immune response specific for the tumor associated antigen prostatic acid phosphatase.)
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AX Other immunostimulants
L03AX17 Sipuleucel-T
D06644 Sipuleucel-T (USP) <US>
New drug approvals in the USA [br08319.html]
Cellular and gene therapy products
D06644
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D06644
